4 de fevereiro de 2022: Na Índia, o câncer pode ter sérios efeitos sociais e econômicos, normalmente resultando em miséria familiar e injustiça social. Neste país demograficamente jovem, as taxas de incidência de câncer ajustadas por idade relatadas ainda são bastante baixas. Em uma população de 1.3 bilhão de pessoas, pouco mais de 1 milhão de novos casos de câncer são detectados a cada ano. Em termos ajustados à idade, isso reflete cerca de um quarto da incidência masculina e feminina observada na Europa Ocidental. O câncer, por outro lado, foi responsável por cerca de 600000 a 700000 mortes na Índia em 2012.
De acordo com a análise Global Burden of Disease Study 2019 do estudo IHME, o quadro não é particularmente diferente globalmente. Em 2019, o número de novos casos de câncer ultrapassou 23 milhões, contra 18.7 milhões em 2010. Em 2019, houve 10 milhões de mortes por câncer, contra 8.29 milhões em 2010. Esses resultados mostram um aumento de 20.9% e 26.3%, respectivamente .
In both developing and developed countries, cancer is a leading cause of morbidity and mortality. The majority of the population in many low- and middle-income nations, including India, does not have access to a well-organized and well-regulated cancer care system. When a person is diagnosed with cancer, they are often forced to spend a lot of money on their own health. Such expenses can push entire families into poverty and, when paired with a lack of what are considered acceptable services, can jeopardize social stability. It can be easily said that cancer treatment in India is still in a nascent stage and huge development is required in this field.
There are two major problems cancer patients and their family members face when someone is diagnosed with cancer. One is, where will they get the best and most appropriate treatment, and two, how much money will be required for treatment? Second is the most important question, as the general population in India is still devoid of health insurance. We at CancerFax addresses both these problems. We help cancer patients find most appropriate and economical cancer treatment in India and abroad. CancerFax is working with more than 100 top cancer hospitals in 10 countries like Dana-Farber, Mayo Clinic, Boston Children’s Hospital, Sheba, Asan, Apollo, BLK, Artemis to name a few.
CAR T-Cell therapy is a breakthrough treatment for some kinds of lymphoma, leukemia and multiple myeloma. CancerFax helps patients enroll for Terapia de células T CAR treatment in the USA, Israel and China. Many patients who had previously relapsed blood tumors had no evidence of cancer after CAR T-Cell therapy. It has also aided in the rehabilitation of patients who have previously failed to respond to most traditional cancer therapies. There are more than 300 ongoing clinical trials in the world’s leading cancer centers on this therapy. CAR T-Cell therapy in India is available as clinical trials now. I hope it will be available for commercial treatment very soon.
